Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-28

Clinical Trial Update: Effects of Black Soy Peptide Supplementation on Blood Pressure [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating black soy peptide supplementation for lowering blood pressure in hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Black Soy Peptide Supplement

Snippet

Sponsor: Yonsei University | Conditions: Hypertension | Phase 3 | Status: COMPLETED